皮肤疾病中的LncRNA NEAT1:病理生理学见解和新兴的治疗策略
Ningrui Cao1,2, Lian Wang1, Yaoxin Wang2
1Department of Dermatology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Chinese medical journal
|December 15, 2025
概括
长非编码RNANEAT1与癌症和免疫状况等皮肤疾病有关. 研究探讨了NEAT1的研究.
科学领域:
- 分子生物学分子生物学
- 皮肤病学 皮肤病学
- 遗传学 是一个遗传学.
背景情况:
- 长非编码RNA核光斑组合转录1 (NEAT1) 调节基因表达.
- 失调的NEAT1与各种人类疾病有关,包括癌症和炎症状况.
- 在皮肤疾病中NEAT1的特定作用和治疗潜力需要全面审查.
研究的目的:
- 审查NEAT1在皮肤疾病中的病理生理学作用.
- 讨论针对皮肤疾病的NEAT1的新兴治疗策略.
- 提供关于NEAT1作为诊断生物标志物和治疗点的见解.
主要方法:
- 对皮肤癌和免疫相关皮肤疾病中NEAT1研究的文献综述.
- 分析NEAT1作为竞争性内源RNA (ceRNA) 的功能.
- 检查NEAT1调制的当前和正在发展的治疗方法.
主要成果:
- 在全身性红斑狼 (SLE),亚托皮性皮肤炎 (AD) 和黑色素瘤中,NEAT1被上调调节.
- 在皮肤疾病中,NEAT1充当了向微RNA的ceRNA,并影响免疫细胞功能.
- 在牛皮中NEAT1的作用是复杂的,与相互矛盾的表达数据需要进一步调查.
- 治疗策略包括NEAT1抑制和过度表达.
结论:
- NEAT1在各种皮肤疾病的发病过程中发挥着重要作用.
- 准NEAT1为皮肤疾病提供了有前途的诊断和治疗机会.
- 需要进一步的研究来阐明NEAT1在牛皮的复杂作用.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
02:39lncRNA - Long Non-coding RNAs
3.5K
3.5K
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:41Non-Canonical Wnt Signaling Pathways
8.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.2K
03:18Non-LTR Retrotransposons
13.1K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.1K